ClinicalTrials.gg
RecruitingNCT04198909ECOGUpdated Nov 18, 2026

Optimization of a Non-invasive Electrophysiological Method for Studying the Functionality of Auditory Nerve Fibers

An interventional study of Electrocochleography, electrophysiology thet for analyse the wave I generated by the auditory pathways in Healthy Volunteer and Without Hearing Disorders, sponsored by University Hospital, Clermont-Ferrand. Recruiting at 1 site in France. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Apr 2019, registered Nov 2019).
  • Started Apr 2019; still recruiting 7 years 6 months later.
Updated Nov 18, 2026Results publication addedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Acoustic overexposure can induced temporary or hearing loss. Usually hearing loss is associated with cochlear cell damages. Recently, a new pathological entity was described and called "hidden hearing loss". In animal model, the histopathology revealed a selective reduction in the number of auditory fibers, resulting in a decrease in the amplitude of wave I of the auditory brainstem response. Electrocochleography (Ecog) is a method for recording the electrical potentials of the cochlea (e.g. wave I). In clinical routine, Ecog is performed invasively with sedation or local anesthesia. Actually, a non invasive approach could be perform but it seems necessary to optimize this method and to define reference values in healthy volunteers.

Read the detailed description

The sound overexposure is a major cause of hearing disorders. The installation of hearing disorders can be temporary or permanent. Most of the time the investigators see a rise in hearing thresholds that can be accompanied by tinnitus. However, sometimes-hearing disorders aren't characterized by higher auditory threshold but by a complaint of understanding in noise. Two explanation are the either possible with a lesion at the peripheral level (sensory organ) or central lesion (auditory pathways). Peripheral damage is easily analysed by conventional tests such as the audiogram. Concerning the central lesions, through to the Electrocochleography, one sees a diminution of the wave I which corresponds to the nerve fiber injury. The wave I can more easily be analysed by the Electrocochleography method. This technique previously used an electrode deposited trans-tympanically in contact with the sensory organ. But, the evolution of a non-invasive technique is now available. However, several assemblies of the electrode are then possible without knowing the impact of these on the morphology of the wave I. Moreover, no normative values are also referenced in the literature on the population without hearing problems. It's in this context that clinical study is carried out in order to optimize the technique on the assembly of the electrode and the acoustic stimulation delivered. After this analyses and obtaining an optimal technique it's envisaged to study the morphology of the wave I in healthy volunteers aged 18-25 years. A pre-inclusion visit will verify the volunteers doesn't have a hearing disorders through a questionnaire, otoscopy, tympanometry and audiometry. Then two steps will be realized. The first is to evaluate the morphology of wave I according to assembly of electrode and acoustic stimulation delivered (machine calibration or calibration in the external auditory canal). The second step will provide normative values for people 18-25 years old who aren't hearing-impaired. Volunteers will have the choice to participate in one or both stages. The aim is to obtain wave I reference values for Electrocochleography technique. The secondary objectives are to analyse the impact of the assembly of the electrode and the adaptation of the acoustic stimulation presented.

02

Conditions studied

  • Healthy Volunteer
  • Without Hearing Disorders

Keywords

  • hidden hearing loss
  • questionnaire
  • hearing screening
  • electrocochleography
03

In context

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 177 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between 18 and 55 years old
  • be affiliated to a social security system
  • understand (oral and written) of the French language
  • be a qualified hearing with normal tympanogram and audiogram

Exclusion criteria

Exclusion Criteria:

  • have a complaint of hearing
  • have a exposure to noise (professional and/or activities)
  • refusal to participate in the study
  • have ear infections and/or ENT medical history
  • have cardiovascular, metabolic, neurological and psychiatric desease
  • being a protected person
  • healthy volunteer who has received compensation equal to or greader than 4500€ in clinical study
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    Cohort 1

    Diagnostic Test: Electrocochleography, electrophysiology thet for analyse the wave I generated by the auditory pathways

Interventions

  • Diagnostic testElectrocochleography, electrophysiology thet for analyse the wave I generated by the auditory pathways

    Electrocochleography is a technique that analyses the functionality of inner ear.

06

What researchers measure

Primary outcomes

  1. Latency of wave I by electrocochleography

    The wave I analyzed at electrocochleography will allow to obtain the latency (milliseconds) of action potential (AP)

    Time frame: Day 180

  2. Latency of wave I by electrocochleography

    The wave I analyzed at electrocochleography will allow to obtain the latency (milliseconds) of action potential (AP)

    Time frame: Day 360

Secondary outcomes

  1. Hearing thresholds in decibels

    The audiometry will make it possible to obtain the hearing thresholds in decibels for all frequency of 250, 500, 750, 1000, 1500, 2000, 3000, 4000, 6000, 8000, 9000, 10000, 11200, 12500 and 14000 Hz.

    Time frame: Day -1 , Day 180, Day 360

  2. Acoustic reflex thresholds in decibels

    The acoustic reflex allows to evaluate the trigger threshold in decibels of the reflex for the frequencies 500, 1000, 2000, 4000Hz.

    Time frame: Day -1 , Day 180, Day 360

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Beaud-Henry L, Mulliez A, Renault A, Bouton K, Avan P, Giraudet F. Exploring electrode montasges to optimize the non-invasive clinical recording of auditory evoked AP/wave I. Clin Neurophysiol Pract. 2026 Jul 4;11:543-550. doi: 10.1016/j.cnp.2026.07.001. eCollection 2026. PubMed 42436816 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2019 (actual). Primary completion is estimated for Apr 2028, 108 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 28, 2019
First posted
Dec 13, 2019
StartActual
Apr 29, 2019
Primary completionEst.
Apr 2028
CompletionEst.
Apr 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Publications
Results publication added: Beaud-Henry L, Mulliez A, Renault A, Bouton K, Avan P, Giraudet F. Exploring electrode montasges to optimize the non-invasive clinical recording of auditory ev… PubMed 42436816 ↗
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Publications Results publication added: Beaud-Henry L, Mulliez A, Renault A, Bouton K, Avan P, Giraudet F. Exploring electrode montasges to optimize the non-invasive clinical recording of auditory ev… PubMed 42436816 ↗

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04198909
Collaborators
Laboratory of Neurosensory Biophysics - UMR INSERM 1107., Foundation of Gueules Cassées, Region of Auvergne-Rhône-Alpes
Responsible party
Sponsor
First posted
Dec 13, 2019
Start date
Apr 29, 2019
Primary completion
Apr 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Lise Laclautre
Contact
promo_interne_drci@chu-clermontferrand.fr
334.73.754.963
Fabrice Giraudet
principal investigator · Université d'Auvergne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion